Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Physiology. Endocrinology and Metabolism|March 22, 2023
Selenoprotein P deficiency protects against immobilization-induced muscle atrophy by suppressing atrophy-related E3 ubiquitin ligasesHalimulati Abuduwaili, Kyoko Kamoshita, Kiyo-Aki Ishii, et al.
Modern Rheumatology|February 2, 2022
The prevalence of locomotive syndrome and its associated factors in patients with Type 2 diabetes mellitusMakoto Handa, Satoshi Kato, Goro Sakurai, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 26, 2023
Study Protocol for the Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitor on Organ-Specific Sympathetic Nerve Activity and Insulin Sensitivity in Participants with Type 2 DiabetesYumie Takeshita, Chiaki Nomura, Hisayoshi Murai, et al.
Cardiovascular Diabetology|October 9, 2015
High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetesRyotaro Bouchi, Takato Takeuchi, Momoko Akihisa, et al.
Journal of Diabetes Investigation|June 23, 2016
Retrograde pyelonephritis and lumbar spondylitis as a result of Salmonella typhi in a type 2 diabetes patient with neurogenic bladderTatsuya Fukuda, Ryotaro Bouchi, Isao Minami, et al.
Journal of Diabetes Investigation|October 20, 2021
Effects of eicosapentaenoic acid on serum levels of selenoprotein P and organ-specific insulin sensitivity in humans with dyslipidemia and type 2 diabetesYumie Takeshita, Chisato Teramura, Kyoko Kamoshita, et al.
Endocrinology|May 23, 2024
LECT2 Deletion Exacerbates Liver Steatosis and Macrophage Infiltration in a Male Mouse Model of LPS-mediated NASHRyota Tanida, Hisanori Goto, Hiroaki Takayama, et al.
Endocrine-Related Cancer|July 28, 2017
Molecular characteristics of the KCNJ5 mutated aldosterone-producing adenomasMasanori Murakami, Takanobu Yoshimoto, Kazuhiko Nakabayashi, et al.
Clinical Endocrinology|November 11, 2022
Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney diseaseYujiro Nakano, Masanori Murakami, Kazunari Hara, et al.
Pageof 6